Peer Review History
| Original SubmissionFebruary 14, 2022 |
|---|
|
PONE-D-22-04583Development of Microfluidic Chip for Entrapping Tobacco BY-2 CellsPLOS ONE Dear Dr. Notaguchi, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please submit your revised manuscript by May 07 2022 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file. Please include the following items when submitting your revised manuscript:
If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Hiroshi Yabu, PhD Academic Editor PLOS ONE Journal Requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. 3. We note that the grant information you provided in the ‘Funding Information’ and ‘Financial Disclosure’ sections do not match. When you resubmit, please ensure that you provide the correct grant numbers for the awards you received for your study in the ‘Funding Information’ section. 4. Thank you for stating the following financial disclosure: "This work was supported by grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (18K05373 and 20H05501 to RT, 18KT0040, 18H03950, and 21H00368 to MN and 20H03273 to KK and MN), Grant-in-Aid for Scientific Research on Innovative Areas (20H05358 to DK), the Japan Science and Technology Agency PRESTO program (JPMJPR18K4 to DK), and the Canon Foundation (R17-0070 to MN)." Please state what role the funders took in the study. If the funders had no role, please state: "The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript." If this statement is not correct you must amend it as needed. Please include this amended Role of Funder statement in your cover letter; we will change the online submission form on your behalf. 5. Thank you for stating the following in the Funding Section of your manuscript: "This work was supported by grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (18K05373 and 20H05501 to RT, 18KT0040, 18H03950, and 21H00368 to MN and 20H03273 to KK and MN), Grant-in-Aid for Scientific Research on Innovative Areas (20H05358 to DK), the Japan Science and Technology Agency PRESTO program (JPMJPR18K4 to DK), and the Canon Foundation (R17-0070 to MN)." We note that you have provided funding information that is not currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: "This work was supported by grants from the Japan Society for the Promotion of Science Grants-in-Aid for Scientific Research (18K05373 and 20H05501 to RT, 18KT0040, 18H03950, and 21H00368 to MN and 20H03273 to KK and MN), Grant-in-Aid for Scientific Research on Innovative Areas (20H05358 to DK), the Japan Science and Technology Agency PRESTO program (JPMJPR18K4 to DK), and the Canon Foundation (R17-0070 to MN)." Please include your amended statements within your cover letter; we will change the online submission form on your behalf. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? The manuscript must describe a technically sound piece of scientific research with data that supports the conclusions. Experiments must have been conducted rigorously, with appropriate controls, replication, and sample sizes. The conclusions must be drawn appropriately based on the data presented. Reviewer #1: Yes Reviewer #2: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? Reviewer #1: Yes Reviewer #2: Yes ********** 3. Have the authors made all data underlying the findings in their manuscript fully available? The PLOS Data policy requires authors to make all data underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data—e.g. participant privacy or use of data from a third party—those must be specified. Reviewer #1: Yes Reviewer #2: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English? PLOS ONE does not copyedit accepted manuscripts, so the language in submitted articles must be clear, correct, and unambiguous. Any typographical or grammatical errors should be corrected at revision, so please note any specific errors here. Reviewer #1: Yes Reviewer #2: Yes ********** 5. Review Comments to the Author Reviewer #1: The authors prepared microfluidic device to trap BY-2 cells and to evaluate physiological activity. Basically, the work shown in the manuscript is technically sounds and give a new device to evaluate cells especially those having filament-like morphology. But some points listed below should be revised before publication. 1) The authors designed microfluidic channels as shown in Figure 2, but what is the principle of the design? In order to trap cells the channel sizes and shapes should be well-considered and it should has specific design. What is the key parameters to determine the design of microfluidic channels? 2) Basically, the end of channel is open, therefore most of cells can be flow away and did not entrapped in the channels. Why did the authors design this type of open channels? 3) Regarding photobleaching, the recovery of fluorescent was not obvious. Is it sufficient intensity to say "recover"? Furthermore, please explain how the authors detect those slight difference. 4) Figure resolution is not high enough. Please upload more clear images. Reviewer #2: This paper describes a study of trapping plant cells with a microchannel device for in-situ culture and observation. The cell filament trapped in the microchannel were shown to retain cell proliferation ability in it. Furthermore, the authors have succeeded in obtaining important information on cell-to-cell protein transport from fluorescence observations such as FRAP. Therefore, this manuscript should be published after some minor revisions, (1) Page12, Line207, the authors claim that the entrapment frequency is 22.3%. On the other hand, in Ref.28, although it is a microparticle, it is trapped more efficiently. It is necessary to describe the difference from the case of cell filaments. (2) In fig.3C More than half of the trapped filaments consists of two cells. Why is the number 2?, Is there a correlation with the length of the minor axis of the approximate minimum ellipse? (3) In fig.4D the mitotic indexes of the trapped BY-2 cell is slightly larger than that of the sorted filament. Why? (4) In the FRAP experiment, please describe the wavelength and power of the irradiation laser light. (5) Line 285, the remained rate of the filament during cultivation in microdevice is discussed. The authors claim that it is likely due to medium flow. However, the number of filament cells after 4 days increased 13.6 times (Fig. 4C), so is the effect possible? (6) In Fig. 5A, is the photobleached area part of a “single cell”? ********** 6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy. Reviewer #1: No Reviewer #2: Yes: Yasutaka Matsuo [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Development of Microfluidic Chip for Entrapping Tobacco BY-2 Cells PONE-D-22-04583R1 Dear Dr. Notaguchi, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice for payment will follow shortly after the formal acceptance. To ensure an efficient process, please log into Editorial Manager at http://www.editorialmanager.com/pone/, click the 'Update My Information' link at the top of the page, and double check that your user information is up-to-date. If you have any billing related questions, please contact our Author Billing department directly at authorbilling@plos.org. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Hiroshi Yabu, PhD Academic Editor PLOS ONE Additional Editor Comments (optional): The authors responded to whole queries from reviewers and I recommend to accept the manuscript to be accepted in PLoS One. |
| Formally Accepted |
|
PONE-D-22-04583R1 Development of Microfluidic Chip for Entrapping Tobacco BY-2 Cells Dear Dr. Notaguchi: I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS ONE. Congratulations! Your manuscript is now with our production department. If your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information please contact onepress@plos.org. If we can help with anything else, please email us at plosone@plos.org. Thank you for submitting your work to PLOS ONE and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Dr. Hiroshi Yabu Academic Editor PLOS ONE |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .